期刊文献+

微小RNA-135a对人胰腺癌细胞增殖和凋亡的影响 被引量:3

Influence of microRNA-135a on proliferation and apoptosis of human pancreatic cancer cells
原文传递
导出
摘要 目的 观察微小RNA-135a(miRNA-135a)对人胰腺癌细胞株Bxpc-3增殖及凋亡的影响.方法 噻唑蓝(MTT)实验检测5-氟尿嘧啶(5-Fu)对Bxpc-3细胞的抑制率,选择合适的5-Fu浓度进行后续实验;流式细胞术检测5-Fu作用后Bxpc-3细胞的凋亡率;实时定量荧光逆转录聚合酶链反应(FQ-PCR)检测5 Fu作用后Bxpc-3细胞miRNA-135a的含量变化.设计miRNA-135a模拟物及反义寡核苷酸链,分别转染Bxpc-3细胞,并转染空病毒组作为对照,RT-qPCR检测各转染组miRNA-135a表达量;MTT法实验检测转染后各组Bxpc-3细胞的增殖率;流式细胞术检测5-Fu作用后各转染组Bxpc-3细胞的凋亡率.结果 5-Fu对胰腺癌细胞Bxpc-3的抑制有浓度和时间依赖性,随着药物浓度增大及作用时间延长,5-Fu对Bxpc-3抑制率增高.经5-Fu处理3、6、12h后miRNA-135a表达量是对照组的(0.45±0.02)、(0.60±0.03)、(0.73±0.02)倍,差异均有统计学意义(P<0.05).转染miRNA-135a模拟物组较空病毒miRNA-135a表达量升高(9.73±0.83)倍,差异有统计学意义(P<0.05);转染miRNA-135a反义寡核苷酸链组是空病毒组miRNA-135a表达量的(0.26±0.01)倍,差异有统计学意义(P<0.05).转染miRNA-135a模拟物组较转染空病毒组细胞增殖率明显升高,相反转染miRNA135反义寡核苷酸链组较转染空病毒组细胞增殖率明显降低.24h后,转染miRNA-135a模拟物组Bxpc-3细胞凋亡率[(12.03±1.07)%]较空病毒组[(20.61±1.53)%]明显降低,差异有统计学意义(P<0.05);转染miRNA-135a反义寡核苷酸链组Bxpc-3细胞凋亡率[(38.20±2.64)%]较空病毒组的(20.61±1.53)%明显升高,差异有统计学意义(P<0.05).结论 5-Fu作用于Bxpc-3细胞后miRNA-135a表达量降低;上调miRNA-135a表达,Bxpc-3细胞的增殖速率升高,Bxpc-3细胞的凋亡率降低;下调miRNA-135a的表达,Bxpc-3细胞增殖率降低,Bxpc-3细胞的凋亡率增高. Objective To investigate the influence of miRNA-135a on the proliferation and apoptosis of the pancreatic cancer cells.Methods Methyl thiazol tetrazolium (MTT) was used to detect the inhibitory effect of 5-fluorouracil (5-Fu) on Bxpc-3 cells and the the appropriate concentration of 5-Fu was chosen in the following experiment.The apoptosis of Bxpc-3 cells was detected by using flow cytometry.Real-time fluorescent quantitative polymerase chain reaction (FQ-PCR) was used to detect the mRNA expression level of miRNA-135a after the Bxpc-3 cells were treated with 5-Fu.The mimic and anti-miRNA oligonuclotide (AMO) were designed and transfected into Bxpc-3 cells,and the Bxpc-3 cells transfected with vehicle served as control group.FQ-PCR was used to detect the expression of miRNA-135a and the proliferation rate was detected by using MTT assay.Flow cytometry was used to detect the apoptosis of transfected Bxpc-3 cells after treatment with 5-Fu.Results The 5-Fu inhibited Bxpc-3 cells in a concentration-and time-dependent manner.With the increase of concentration and prolongation of time,the inhibition rate of 5-Fu was elevated.The miRNA-135a level was reduced to (0.45 ±0.02),(0.60 ±0.03)and (0.73 ± 0.02) times after treatment with 5-Fu (P 〈 0.05 for all).After transfection the mRNA levels of miRNA-13a was elevated (9.73 ±0.83) times in the mimic groups and reduced to (0.26 ±0.01) times in the AMO groups as compared with the vehicle groups (P 〈 0.05 for all).The proliferation of Bxpc-3 cells was elevated in the mimic group and reduced in the AMO group as compared with the vehicle group.The apoptosis of Bxpc-3 cells,which was (12.03 1.07) %,was reduced significantantly in the mimic groups as compared with the vehicle groups [(20.61 ± 1.53) %] (P 〈 0.05),while the apoptosis was elevated in the AMO groups [(38.20 ±2.64)%] (P 〈0.05).Conclusion The level of miRNA-135a was lower in Bxpe-3 cells treated with 5-Fu.The up-regulated expression of miRNA-135
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第1期28-31,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30972928、31140078)
关键词 胰腺癌 微小RNA 脱噬作用 Pancreatic cancer MicroRNA Apoptosis
  • 相关文献

参考文献4

二级参考文献66

  • 1Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297. 被引量:1
  • 2Bagels CL and Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Ann Biol Clin (Paris) 2010, 68:263-272 [Article in French]. 被引量:1
  • 3Kunej T, Godnic I, Horvat S, Zorc M and Calin GA. Cross talk between micmRNA and coding cancer genes. Cancer J 2012, 18: 223-231. 被引量:1
  • 4Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M and Nitti D. miRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta 2010, 411:1181-1186. 被引量:1
  • 5Dong Y, Wu WK, Wu CW, Sung JJ, Yu J and Ng SS. MicmRNA dysregu- lation in colorectal cancer: a clinical perspective. Br J Cancer 2011, 104: 893-898. 被引量:1
  • 6Heneghan HM, Miller N and Kerin MJ. MiRNAs as biomarkers and them- peutic targets in cancer. Curt Opin Pharrnacol 2010, 10: 543-550. 被引量:1
  • 7Manne U, Shanmugam C, Bovell L, Katkoori VR and Bumpers HL. miRNAs as biomarkers for management of patients with colorectal cancer. Biomark Med 2010, 4:761-770. 被引量:1
  • 8Luo H, Zou J, Dong Z, Zeng Q, Wu D and Liu L. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting RND3 tumour suppressor gene in colorectal carcinoma. Biochem J 2012, 442: 311-321. 被引量:1
  • 9Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T and Ueda S, et al. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 2011, 102: 2264-2271. 被引量:1
  • 10Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gala R and Xiao L, et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012, 142: 886-896.e9. 被引量:1

共引文献38

同被引文献10

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部